EnGene Holdings Financial Statements From 2010 to 2026

ENGN Etf  USD 9.55  0.69  7.79%   
EnGene Holdings' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing EnGene Holdings' valuation are provided below:
Market Capitalization
593.5 M
Earnings Share
(2.29)
enGene Holdings Common does not currently have any fundamental signals for analysis.
Check EnGene Holdings financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among EnGene Holdings' main balance sheet or income statement drivers, such as , as well as many indicators such as . EnGene financial statements analysis is a perfect complement when working with EnGene Holdings Valuation or Volatility modules.
This module can also supplement various EnGene Holdings Technical models . Check out the analysis of EnGene Holdings Correlation against competitors.

Pair Trading with EnGene Holdings

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if EnGene Holdings position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in EnGene Holdings will appreciate offsetting losses from the drop in the long position's value.

Moving together with EnGene Etf

  0.73DNTH Dianthus TherapeuticsPairCorr

Moving against EnGene Etf

  0.73WINT Windtree TherapeuticsPairCorr
  0.7ESLA Estrella ImmunopharmaPairCorr
  0.67VTGN VistaGen TherapeuticsPairCorr
  0.66DWTX Dogwood TherapeuticsPairCorr
  0.66VRAX Virax Biolabs GroupPairCorr
The ability to find closely correlated positions to EnGene Holdings could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace EnGene Holdings when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back EnGene Holdings - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling enGene Holdings Common to buy it.
The correlation of EnGene Holdings is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as EnGene Holdings moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if enGene Holdings Common moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for EnGene Holdings can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Other Information on Investing in EnGene Etf

EnGene Holdings financial ratios help investors to determine whether EnGene Etf is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in EnGene with respect to the benefits of owning EnGene Holdings security.